Cargando…
To learn or not to learn from real-world experience on direct oral anticoagulants in pediatric patients?
Autor principal: | Streif, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031373/ https://www.ncbi.nlm.nih.gov/pubmed/36970739 http://dx.doi.org/10.1016/j.rpth.2022.100034 |
Ejemplares similares
-
What can we learn from real world studies on direct oral anticoagulants?
por: Coppens, M.
Publicado: (2017) -
Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022) -
Direct oral anticoagulants in extremely obese patients: OK to use?
por: Moll, Stephan, et al.
Publicado: (2018) -
Therapeutic Monitoring of Direct Oral Anticoagulants—Back to the Future?
por: Hu, Kai, et al.
Publicado: (2020) -
What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future?
por: Betensky, Marisol, et al.
Publicado: (2023)